Australian Doctor 19th April issue | Page 8

8 NEWS

8 NEWS

19 APRIL 2024 ausdoc . com . au

RACGP settles KFP meltdown

Heather Saxena THE RACGP has settled out of court
around 40 minutes after the first group of registrars started .
million or more for the implosion . In 2023 , it sued Genix Ventures .
two weeks ’ notice because of concerns around a computer glitch and
with a software company four years
It took four hours for the RACGP to
Last month the college informed
subsequently swore off computer
after its remote exam meltdown lost
call off the exam while registrars ago-
members that it had settled the
exams “ for the foreseeable future ”.
the college millions of dollars .
nised over whether to contact the col-
case but could not release details of
Other colleges have dealt with
The confidential settlement with
lege and risk an automatic fail for using
the settlement .
computer exam crashes , includ-
Genix Ventures relates to its Key Fea-
their phones under exam conditions .
The RACGP has never released
ing the Royal Australasian College
ture Problem ( KFP ) exam held in
The Applied Knowledge Test ,
its internal review into the debacle ,
of Physicians in 2018 and the Royal
2020 during the COVID-19 pandemic .
scheduled for the following day , was
a decision that caused some regis-
Australian and New Zealand Col-
Some 1400 registrars were taking
also scrapped amid fears of a repeat .
trars to threaten their own lawsuit
lege of Psychiatrists in 2021 .
the exam at home when it was aborted
The RACGP refunded around $ 6
against the RACGP .
Around 50 ACRRM registrars
because of technical issues .
million in exam fees and allowed
While the RACGP planned to
had to resit a three-hour exam in
The exam — already delayed three
registrars to resit exams for free ,
return to a computer-based KFP exam
2020 , because the software stopped
months due to COVID-19 — crashed
setting a cost of potentially $ 10
in 2023 , it changed the plan with just
recording their answers .
Write-off here and ideally three lines if possible please , thankyou Obitius molupienime quat im num nume sust , simus doluptas
LOWEST LDL-C IS BEST * 1 , 2
Learn more at beyondstatins . com . au
* There is a linear association between lower LDL-C and lower CV risk in secondary prevention studies , with no lower limit for the association ( or ‘ J-curve ’ effect ). 1 , 2
Cancer , karma and the love of patients
PAGE 3 diagnosed , I thought , that ’ s kind of karma , isn ’ t it ? An eye for eye , a myeloma for a myeloma .
You tend to go back and revisit your mistakes and your guilt when you have something like this .
Australian Doctor : Have you made peace with the possibility that this illness might shorten your life ?

PREVENT

ANOTHER CV EVENT † 3 , 4

Repatha ® is indicated for the prevention of CV events ( MI , stroke and coronary revascularisation ) in adults with established CV disease in combination with an optimally dosed statin and / or other lipid-lowering therapies , as an adjunct to diet and exercise . 3
‘ Power ’: 15 % relative risk reduction with Repatha ® vs placebo in the composite of the primary endpoint beyond optimised statin ± ezetimibe ( HR : 0.85 ; 95 % CI : 0.79 – 0.92 , p < 0.001 ). 4
PBS Information : Authority Required . Non-familial and familial hypercholesterolaemia . Criteria apply for certain patient populations . Refer to PBS Schedule for full Authority Required Information .
† 3,4
Dr Goldsworthy : That ’ s never been a problem .
I ’ ve had a wonderful life , and a hugely lucky life , surrounded by people who love me .
There are still plenty of things to explore in the world .
New tastes , music and books , and I just won ’ t be able to do that maybe as intensely as I was planning . We ’ re all going to die . I ’ m actually getting pretty confident that I ’ ll die of something else , the way it ’ s going .
I ’ m six years in and I ’ m doing pretty well .
Every now and then a drug stops working and they give you a new one , and this is the fifth chemo drug I ’ ve tried .
It could work for six months , or it could work for six years .
It ’ s out of my hands .
Dr Goldsworthy spoke to Carmel Sparke
Refer to full Product Information before prescribing ; available from Amgen Australia Pty Ltd , Ph : 1800 803 638 or by scanning the QR code : For more information on Repatha ® or to report an adverse event or product complaint involving Repatha ® , please contact Amgen Medical Information on 1800 803 638 or visit www . amgenmedinfo . com . au .
Precautions : Hypersensitivity reactions . Concomitant lipid lowering therapies – check all relevant prescribing information . Effects of long-term very low LDL-C levels are unknown . Immunogenic potential . Pregnancy Category : B1 . Caution – breastfeeding . Adverse Reactions : Common – nasopharyngitis , upper respiratory tract infection , influenza , back pain , arthralgia , nausea , rash , and injection site reactions ( including injection site pain , erythema , bruising , swelling or haemorrhage ).
Abbreviations : CI , confidence interval ; CV , cardiovascular ; HR , hazard ratio ; LDL-C , low-density lipoprotein cholesterol ; MI , myocardial infarction ; PBS , Pharmaceutical Benefits Scheme .
References : 1 . Mach F , et al . Eur Heart J 2020 ; 41 ( 1 ): 111 – 188 . 2 . Packard C , et al . Heart 2021 ; 107:1369 – 1375 . 3 . Repatha ® ( evolocumab ) product information . 4 . Sabatine MS , et al . N Engl J Med 2017 ; 376:1713 – 1722 .
Amgen Australia Pty Ltd . ABN 31 051 057 428 , Sydney NSW 2000 . © 2024 Amgen Inc . All rights reserved . AUS-145-0124-80028 . AMG8657 . Date of preparation : February 2024
AMG8657 _ Repatha Print Media 24 _ Aus Doc _ A4 _ 210x273 _( MALE )_ V0.4 _ FA . indd 1 5 / 2 / 2024 3:31 pm